glp-1 and exercise on GLP-1s: how to stay strong while losing weight Saturday Science: EXERCISE plus GLP-1

Full descriptions of the individual ingredients are not included

There were no significant associations between the receptor expression status and the clinicopathological features

Katerina Gallus with Restore SD Plastic Surgery

Diabetes Care 42 , 14961503 (2019)

References (this section): NEJM (2023): Phase 2 trial publication Eli Lilly: Phase 2 results (mentions 24.2% at 48 weeks as a secondary endpoint) Eli Lilly (Dec 2025): Phase 3 TRIUMPH-4 topline results announcement Retatrutide side effects: what trials report (not medical advice) Searches like retatrutide side effects and side effects of retatrutide usually refer to events reported in clinical trial publications and sponsor summaries